Reeovision

Company Overview

Snapshot

Founded in January 2023 by Ronen Einat and Yaniv Barkana, Reeovision operates with 1–10 employees. The company has secured funding across one round, raising $25K. Reeovision is focused on developing an innovative full-field Optical Coherence Tomography (OCT) device for ophthalmology.

Business overview

Reeovision is developing a breakthrough medical imaging device for ophthalmology, combining full-field Optical Coherence Tomography (OCT) with fundus imaging. Its core technology provides full-volume 3D mapping and internal depth information of tissues, addressing limitations of current sparse line-based OCT systems. The company aims to deliver a small, cost-effective, multi-modality device that enhances diagnostic quality and accuracy for conditions like glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy, serving the medical devices industry within the Health Tech & Life Sciences sector.

Company Intelligence Q&A

When was Reeovision founded?

Reeovision was founded in January 2023.

Who are the founders of Reeovision?

The founders of Reeovision are Ronen Einat and Yaniv Barkana.

What is Reeovision's primary focus?

Reeovision's primary focus is on making a breakthrough in medical imaging by developing the first commercial Optical Coherence Tomography (OCT) device that delivers full-volume 3D mapping along with other imaging modalities, particularly for ophthalmology.

What kind of technology does Reeovision utilize?

Reeovision utilizes full-field imaging techniques for Optical Coherence Tomography (OCT) analysis, enabling high-resolution 3D information of surface structure and internal depth of transparent materials and tissues.

What is the current employee size of Reeovision?

Reeovision currently has 1–10 employees.